Below is a list of individual analysts that we are aware of that currently follow ContraVir Pharmaceuticals.
Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent ContraVir Pharmaceuticals or its management team. ContraVir Pharmaceuticalsis under no obligation to update this list, thus it may not be complete or up to date.
David Bautz, Ph.D.
Zacks Investment Research, Inc.
Noble Life Science Partners
Maxim Group, LLC
Laidlaw & Company